AIIMS director says not much evidence of Covid-19 community spread at national level, but there are hotspots

AIIMS in Delhi is scheduled to start phase I/II of human clinical trials of the indigenously developed Covid-19 vaccine candidate ‘Covaxin’ today


Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email